A Preliminary Risk-Benefit Assessment of Latanoprost and Unoprostone in Open-Angle Glaucoma and Ocular Hypertension

Author： Eisenberg D.L.   Camras C.B.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.20, Iss.6, 1999-06, pp. : 505-514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Unoprostone Isopropyl as Mono- or Adjunctive Therapy in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

By Mello P.A.d.A.  

Drug Safety, Vol. 25, Iss. 8, 2002-01 ,pp. : 583-597

Adis International

Access to resources Recommend Favorite

An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension

By Feldman Robert M  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 909-921

Informa Healthcare

Access to resources Recommend Favorite

Brinzolamide/Timolol: In Open-Angle Glaucoma and Ocular Hypertension

By Croxtall Jamie D.   Scott Lesley J.  

Drugs & Aging, Vol. 26, Iss. 5, 2009-05 ,pp. : 437-446

Adis International

Access to resources Recommend Favorite

Topical Bimatoprost: A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension

By Easthope S.E.   Perry C.M.  

Drugs & Aging, Vol. 19, Iss. 3, 2002-01 ,pp. : 231-248

Adis International

Access to resources Recommend Favorite

Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension

By Plosker Greg L.   Keam Susan J.  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 297-314

Adis International

Access to resources Recommend Favorite